Costello et al [18] found that human acute myeloid leukemia CD34+/CD38− progenitor cells exhibited that decreasing sensitivity to daunorubicin (a chemotherapeutic agent) compared with CD34+/CD38+ cells, as well as high expression levels of the drug resistance-related genes LRP and MRP. Here, CD38 is linked to acute myeloid leukemia.